EGFR and osteosarcoma: EGFR-immobilized Sali-loaded nanoparticles proved more effective in inhibiting the proliferation of U2O2 and MG-63 osteosarcoma cells and reducing the tumorsphere formation rate than the nontargeted nanoparticles and free Sali.